noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

OSE Immunotherapeutics SA

10/11/2021 | Press release | Distributed by Public on 10/10/2021 23:31

OSE Immunotherapeutics annonce l’accord de délivrance d’un nouveau brevet sur Tedopi® en Europe – Ce brevet renforce la propriété intellectuelle de Tedopi® jusqu’en 2038

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | OSE Immunotherapeutics SA | News | Health | Company News | Arts and Culture | Public Companies | Pharmaceutical Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | OTC Markets | Euronext Paris | Cboe Off Exchange | Euronext Block MTF

Back

Download the original document